Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1151

1.

Inter-Technique Consistency and Prognostic Value of Intra-Procedural Angiographic and Echocardiographic Assessment of Aortic Regurgitation After Transcatheter Aortic Valve Implantation.

Tateishi H, Miyazaki Y, Okamura T, Abdelghani M, Modolo R, Wada Y, Okuda S, Omuro A, Ariyoshi T, Fujii A, Oda T, Fujimura T, Nanno T, Mikamo A, Soliman OII, Onuma Y, Hamano K, Yano M, Serruys PW.

Circ J. 2018 Jul 5. doi: 10.1253/circj.CJ-17-1376. [Epub ahead of print]

2.

PD-L1-Expressing Radiation-Associated Angiosarcoma after Primary Breast Cancer.

Takeda K, Fujimura T, Lyu C, Tsukada A, Tsuchiyama K, Hashimoto A, Aiba S.

Case Rep Oncol. 2018 May 29;11(2):330-335. doi: 10.1159/000489628. eCollection 2018 May-Aug.

3.

Two cases of dabrafenib and trametinib therapy-failed advanced melanoma successfully controlled by nivolumab monotherapy.

Sato Y, Fujimura T, Kambayashi Y, Tanita K, Tono H, Hashimoto A, Aiba S.

J Dermatol. 2018 Jun 20. doi: 10.1111/1346-8138.14508. [Epub ahead of print]

PMID:
29923635
4.

Metastasectomy of Hepatoblastoma Utilizing a Novel Overlay Fluorescence Imaging System.

Yamada Y, Hoshino K, Mori T, Kawaida M, Abe K, Takahashi N, Fujimura T, Kameyama K, Kuroda T.

J Laparoendosc Adv Surg Tech A. 2018 Jun 15. doi: 10.1089/lap.2017.0735. [Epub ahead of print]

PMID:
29906233
5.

Prognostic significance of neutrophil-to-lymphocyte ratio in collecting duct carcinoma.

Taguchi S, Fukuhara H, Miyakawa J, Morikawa T, Naito A, Kawai T, Fujimura T, Kume H.

Jpn J Clin Oncol. 2018 Jul 1;48(7):692-694. doi: 10.1093/jjco/hyy076.

PMID:
29846639
6.

Assessment of the methods used to detect HER2-positive advanced extramammary Paget's disease.

Hirai I, Tanese K, Nakamura Y, Otsuka A, Fujisawa Y, Yamamoto Y, Hata H, Fujimura T, Matsushita S, Yoshino K, Kameyama K, Amagai M, Funakoshi T.

Med Oncol. 2018 May 9;35(6):92. doi: 10.1007/s12032-018-1154-z.

PMID:
29744813
7.

Tension-free vaginal mesh surgery versus laparoscopic sacrocolpopexy for pelvic organ prolapse: Analysis of perioperative outcomes using a Japanese national inpatient database.

Obinata D, Sugihara T, Yasunaga H, Mochida J, Yamaguchi K, Murata Y, Yoshizawa T, Matsui T, Matsui H, Sasabuchi Y, Fujimura T, Homma Y, Takahashi S.

Int J Urol. 2018 Jul;25(7):655-659. doi: 10.1111/iju.13587. Epub 2018 May 5.

PMID:
29729035
8.

Clinical significance of random bladder biopsy in primary T1 bladder cancer.

Otsuka M, Taguchi S, Nakagawa T, Morikawa T, Maekawa S, Miyakawa J, Matsumoto A, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.

Mol Clin Oncol. 2018 May;8(5):665-670. doi: 10.3892/mco.2018.1587. Epub 2018 Mar 8.

9.

COBLL1 modulates cell morphology and facilitates androgen receptor genomic binding in advanced prostate cancer.

Takayama KI, Suzuki T, Fujimura T, Takahashi S, Inoue S.

Proc Natl Acad Sci U S A. 2018 May 8;115(19):4975-4980. doi: 10.1073/pnas.1721957115. Epub 2018 Apr 23.

PMID:
29686105
10.

Successful Treatment of Advanced Primary Cutaneous Peripheral T-Cell Lymphoma with Oral Bexarotene Monotherapy.

Sato Y, Fujimura T, Kambayashi Y, Hashimoto A, Aiba S.

Case Rep Oncol. 2018 Mar 28;11(1):212-215. doi: 10.1159/000488236. eCollection 2018 Jan-Apr.

11.

Three patients with advanced cutaneous angiosarcoma treated with eribulin: investigation of serum soluble CD163 and chemokine (C-X-C motif) ligand 10 as possible biomarkers predicting the biological behaviour of angiosarcoma.

Fujimura T, Sato Y, Kambayashi Y, Tanita K, Tsukada A, Terui H, Hashimoto A, Aiba S.

Br J Dermatol. 2018 Apr 17. doi: 10.1111/bjd.16676. [Epub ahead of print]

PMID:
29663331
12.

Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study.

Fujimura T, Sato Y, Tanita K, Kambayashi Y, Otsuka A, Fujisawa Y, Yoshino K, Matsushita S, Funakoshi T, Hata H, Yamamoto Y, Uchi H, Nonomura Y, Tanaka R, Aoki M, Imafuku K, Okuhira H, Furudate S, Hidaka T, Aiba S.

Oncotarget. 2018 Feb 15;9(21):15542-15551. doi: 10.18632/oncotarget.24509. eCollection 2018 Mar 20.

13.

A Highly Efficient Adsorbent Cu-Perusian Blue@Nanodiamond for Cesium in Diluted Artificial Seawater and Soil-Treated Wastewater.

Matsumoto K, Yamato H, Kakimoto S, Yamashita T, Wada R, Tanaka Y, Akita M, Fujimura T.

Sci Rep. 2018 Apr 11;8(1):5807. doi: 10.1038/s41598-018-24129-0.

14.

Oncological and peri-surgical outcomes of radical prostatectomy for non-metastatic prostate cancer with prostate-specific antigen level of 50 ng/ml or greater.

Makino K, Nakagawa T, Ito E, Kasahara I, Murata T, Fujimura T, Fukuhara H, Homma Y.

Jpn J Clin Oncol. 2018 May 1;48(5):485-490. doi: 10.1093/jjco/hyy044.

PMID:
29635526
15.

Anti-inflammatory intravenous immunoglobulin (IVIg) suppresses homeostatic proliferation of B cells.

Hori A, Fujimura T, Kawamoto S.

Cytotechnology. 2018 Jun;70(3):921-927. doi: 10.1007/s10616-017-0176-2. Epub 2018 Apr 2.

PMID:
29611058
16.

Intensity-Modulated Radiotherapy Triggers Onset of Bullous Pemphigoid in a Patient with Advanced Melanoma Treated with Nivolumab.

Tanita K, Fujimura T, Kambayashi Y, Tsukada A, Sato Y, Hashimoto A, Aiba S.

Case Rep Oncol. 2018 Feb 15;11(1):114-118. doi: 10.1159/000487127. eCollection 2018 Jan-Apr.

17.

Pig testis extract augments adiponectin expression and secretion through the peroxisome proliferator-activated receptor signaling pathway in 3T3-L1 adipocytes.

Kadooka K, Sato M, Matsumoto T, Kuhara S, Katakura Y, Fujimura T.

Cytotechnology. 2018 Jun;70(3):983-992. doi: 10.1007/s10616-018-0213-9. Epub 2018 Mar 26.

PMID:
29582200
18.

Cutaneous Angiosarcoma: The Possibility of New Treatment Options Especially for Patients with Large Primary Tumor.

Fujisawa Y, Yoshino K, Fujimura T, Nakamura Y, Okiyama N, Ishitsuka Y, Watanabe R, Fujimoto M.

Front Oncol. 2018 Mar 2;8:46. doi: 10.3389/fonc.2018.00046. eCollection 2018. Review.

19.

Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study.

Ebina K, Hashimoto M, Yamamoto W, Ohnishi A, Kabata D, Hirano T, Hara R, Katayama M, Yoshida S, Nagai K, Son Y, Amuro H, Akashi K, Fujimura T, Hirao M, Yamamoto K, Shintani A, Kumanogoh A, Yoshikawa H.

PLoS One. 2018 Mar 15;13(3):e0194130. doi: 10.1371/journal.pone.0194130. eCollection 2018.

20.

Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.

Maruyama H, Miyata K, Mikame M, Taguchi A, Guili C, Shimura M, Murayama K, Inoue T, Yamamoto S, Sugimura K, Tamita K, Kawasaki T, Kajihara J, Onishi A, Sugiyama H, Sakai T, Murata I, Oda T, Toyoda S, Hanawa K, Fujimura T, Ura S, Matsumura M, Takano H, Yamashita S, Matsukura G, Tazawa R, Shiga T, Ebato M, Satoh H, Ishii S.

Genet Med. 2018 Mar 15. doi: 10.1038/gim.2018.31. [Epub ahead of print]

PMID:
29543226
21.

Data on two- and three-dimensional optical coherence tomography guidance for the treatment for the bifurcation lesion.

Nagoshi R, Okamura T, Murasato Y, Fujimura T, Yamawaki M, Ono S, Serikawa T, Hikichi Y, Nakao F, Sakamoto T, Shinke T, Kijima Y, Kozuki A, Shibata H, Shite J.

Data Brief. 2017 Dec 14;16:865-868. doi: 10.1016/j.dib.2017.12.024. eCollection 2018 Feb.

22.

Successful Treatment of Erythrodermic Mycosis Fungoides with Mogamulizumab Followed by Etoposide Monotherapy.

Fujimura T, Tanita K, Sato Y, Kambayashi Y, Furudate S, Tsukada A, Hashimoto A, Aiba S.

Case Rep Oncol. 2018 Jan 16;11(1):29-32. doi: 10.1159/000486278. eCollection 2018 Jan-Apr.

23.

Successful Treatment of Nivolumab-Resistant Multiple In-Transit Melanomas with Ipilimumab and Topical Imiquimod.

Fujimura T, Kambayashi Y, Sato Y, Tanita K, Furudate S, Tsukada A, Tono H, Hashimoto A, Aiba S.

Case Rep Oncol. 2018 Jan 4;11(1):1-5. doi: 10.1159/000485612. eCollection 2018 Jan-Apr.

24.

Inhibitory effects of silodosin on the bladder mechanosensitive afferent activities and their relation with bladder myogenic contractions in male rats with bladder outlet obstruction.

Aizawa N, Watanabe D, Fukuhara H, Fujimura T, Kume H, Homma Y, Igawa Y.

Neurourol Urodyn. 2018 Mar 6. doi: 10.1002/nau.23547. [Epub ahead of print]

PMID:
29508437
25.

HLA-DRB1*04:05 in two cases of Vogt-Koyanagi-Harada disease-like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib/trametinib therapy.

Fujimura T, Kambayashi Y, Tanita K, Sato Y, Hidaka T, Otsuka A, Tanaka H, Furudate S, Hashimoto A, Aiba S.

J Dermatol. 2018 Jun;45(6):735-737. doi: 10.1111/1346-8138.14273. Epub 2018 Feb 27.

PMID:
29488243
26.

Optical Humidity Sensing Using Transparent Hybrid Film Composed of Cationic Magnesium Porphyrin and Clay Mineral.

Fujimura T, Shimada T, Sasai R, Takagi S.

Langmuir. 2018 Mar 27;34(12):3572-3577. doi: 10.1021/acs.langmuir.7b04006. Epub 2018 Mar 13.

PMID:
29485287
27.

Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer.

Fujimura T, Kambayashi Y, Fujisawa Y, Hidaka T, Aiba S.

Front Oncol. 2018 Jan 23;8:3. doi: 10.3389/fonc.2018.00003. eCollection 2018. Review.

28.

Baseline neutrophil to lymphocyte ratio combined with serum lactate dehydrogenase level associated with outcome of nivolumab immunotherapy in a Japanese advanced melanoma population.

Fujisawa Y, Yoshino K, Otsuka A, Funakoshi T, Fujimura T, Yamamoto Y, Hata H, Tanaka R, Yamaguchi K, Nonomura Y, Hirai I, Furudate S, Okuhira H, Imafuku K, Aoki M, Matsushita S.

Br J Dermatol. 2018 Feb 6. doi: 10.1111/bjd.16427. [Epub ahead of print] No abstract available.

PMID:
29405254
29.

Characteristics of hepatic insulin-sensitive nonalcoholic fatty liver disease.

Shigiyama F, Kumashiro N, Furukawa Y, Funayama T, Takeno K, Wakui N, Ikehara T, Nagai H, Taka H, Fujimura T, Uchino H, Tamura Y, Watada H, Nemoto T, Shiraga N, Sumino Y, Hirose T.

Hepatol Commun. 2017 Jul 29;1(7):634-647. doi: 10.1002/hep4.1077. eCollection 2017 Sep.

30.

Association of Impact Velocity with Serious-injury and Fatality Risks to Cyclists in Commercial Truck-Cyclist Accidents.

Matsui Y, Oikawa S, Sorimachi K, Imanishi A, Fujimura T.

Stapp Car Crash J. 2017 Nov;61:355-371.

PMID:
29394445
31.

TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer.

Takayama KI, Suzuki T, Tanaka T, Fujimura T, Takahashi S, Urano T, Ikeda K, Inoue S.

Oncogene. 2018 Apr;37(16):2165-2180. doi: 10.1038/s41388-017-0095-x. Epub 2018 Jan 30.

PMID:
29379164
32.

Association of USP10 with G3BP2 Inhibits p53 Signaling and Contributes to Poor Outcome in Prostate Cancer.

Takayama KI, Suzuki T, Fujimura T, Takahashi S, Inoue S.

Mol Cancer Res. 2018 May;16(5):846-856. doi: 10.1158/1541-7786.MCR-17-0471. Epub 2018 Jan 29.

PMID:
29378906
33.

Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine.

Fujimura T, Takayama K, Takahashi S, Inoue S.

Cancers (Basel). 2018 Jan 23;10(2). pii: E29. doi: 10.3390/cancers10020029. Review.

34.

Development and validation of a facial expression database based on the dimensional and categorical model of emotions.

Fujimura T, Umemura H.

Cogn Emot. 2018 Jan 15:1-8. doi: 10.1080/02699931.2017.1419936. [Epub ahead of print]

PMID:
29334821
35.

Extent of Hunner lesions: The relationships with symptom severity and clinical parameters in Hunner type interstitial cystitis patients.

Akiyama Y, Niimi A, Nomiya A, Yamada Y, Nakagawa T, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.

Neurourol Urodyn. 2018 Apr;37(4):1441-1447. doi: 10.1002/nau.23467. Epub 2018 Jan 9.

PMID:
29315774
36.

Purine salvage in plants.

Ashihara H, Stasolla C, Fujimura T, Crozier A.

Phytochemistry. 2018 Mar;147:89-124. doi: 10.1016/j.phytochem.2017.12.008. Epub 2018 Jan 4. Review.

PMID:
29306799
37.

The Expression of Matrix Metalloproteinases in Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-expressing Cancer of Apocrine Origin.

Kambayashi Y, Fujimura T, Furudate S, Lyu C, Hidaka T, Kakizaki A, Sato Y, Tanita K, Aiba S.

Anticancer Res. 2018 Jan;38(1):113-120.

PMID:
29277763
38.

Mechanisms of carnosine-induced activation of neuronal cells.

Yamashita S, Sato M, Matsumoto T, Kadooka K, Hasegawa T, Fujimura T, Katakura Y.

Biosci Biotechnol Biochem. 2018 Apr;82(4):683-688. doi: 10.1080/09168451.2017.1413325. Epub 2017 Dec 11.

PMID:
29224504
39.

Design, Synthesis and Cytotoxicity Evaluation of New 3, 5-Disubstituted-2-Thioxoimidazolidinones.

Abdellatif K, Elbadawi MM, Elsaady MT, El-Hafeez AAA, Fujimura T, Kawamoto S, Khodair AI.

Anticancer Agents Med Chem. 2017 Nov 29. doi: 10.2174/1871520618666171129213838. [Epub ahead of print]

PMID:
29189182
40.

Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.

Matsumoto A, Nakagawa T, Kanatani A, Ikeda M, Kawai T, Miyakawa J, Taguchi S, Naito A, Otsuka M, Nakanishi Y, Suzuki M, Koga F, Nagase Y, Kondo Y, Okaneya T, Tanaka Y, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.

World J Urol. 2018 Feb;36(2):249-256. doi: 10.1007/s00345-017-2141-2. Epub 2017 Nov 28.

PMID:
29185045
41.

Increased serum production of soluble CD163 and CXCL5 in patients with moyamoya disease: Involvement of intrinsic immune reaction in its pathogenesis.

Fujimura M, Fujimura T, Kakizaki A, Sato-Maeda M, Niizuma K, Tomata Y, Aiba S, Tominaga T.

Brain Res. 2018 Jan 15;1679:39-44. doi: 10.1016/j.brainres.2017.11.013. Epub 2017 Nov 22.

PMID:
29174692
42.

Ethnic differences in stratum corneum functions between Chinese and Thai infants residing in Bangkok, Thailand.

Fujimura T, Miyauchi Y, Shima K, Hotta M, Tsujimura H, Kitahara T, Takema Y, Palungwachira P, Laohathai D, Chanthothai J, Nararatwanchai T.

Pediatr Dermatol. 2018 Jan;35(1):87-91. doi: 10.1111/pde.13335. Epub 2017 Nov 15.

PMID:
29143471
43.

Impact of guidewire recrossing point into stent jailed side branch for optimal kissing balloon dilatation: core lab 3D optical coherence tomography analysis.

Okamura T, Nagoshi R, Fujimura T, Murasato Y, Yamawaki M, Ono S, Serikawa T, Hikichi Y, Norita H, Nakao F, Sakamoto T, Shinke T, Shite J.

EuroIntervention. 2018 Feb 2;13(15):e1785-e1793. doi: 10.4244/EIJ-D-17-00591.

44.

Properties of Skin in Chinese Infants: Developmental Changes in Ceramides and in Protein Secondary Structure of the Stratum Corneum.

Yuan C, Zou Y, Xueqiu Y, Shima K, Miyauchi Y, Naoe A, Naito S, Fujimura T, Hotta M, Kitahara T, Wang X.

Biomed Res Int. 2017;2017:3594629. doi: 10.1155/2017/3594629. Epub 2017 Oct 2.

45.

Retrospective study of advanced melanoma patients treated with ipilimumab after nivolumab: Analysis of 60 Japanese patients.

Fujisawa Y, Yoshino K, Otsuka A, Funakoshi T, Uchi H, Fujimura T, Matsushita S, Hata H, Okuhira H, Tanaka R, Nagai K, Ishida Y, Nakamura Y, Furudate S, Yamamura K, Imafuku K, Yamamoto Y.

J Dermatol Sci. 2018 Jan;89(1):60-66. doi: 10.1016/j.jdermsci.2017.10.009. Epub 2017 Oct 25.

PMID:
29079332
46.

Serial changes in the side-branch ostial area after main-vessel stenting with kissing balloon inflation for coronary bifurcation lesions, assessed by 3D optical coherence tomography.

Fujimura T, Okamura T, Tateishi H, Nakamura T, Yamada J, Oda T, Mochizuki M, Nishimura S, Nishimura T, Yano M.

Eur Heart J Cardiovasc Imaging. 2017 Oct 23. doi: 10.1093/ehjci/jex213. [Epub ahead of print]

PMID:
29069325
47.

Successful treatment of relapsed folliculotropic mycosis fungoides with mogamulizumab followed by intensity-modulated radiotherapy.

Fujimura T, Furudate S, Tanita K, Sato Y, Kambayashi Y, Hidaka T, Aiba S.

J Dermatol. 2018 Apr;45(4):e84-e85. doi: 10.1111/1346-8138.14111. Epub 2017 Oct 25. No abstract available.

PMID:
29068082
48.
49.

Phase I study of nivolumab combined with IFN-β for patients with advanced melanoma.

Fujimura T, Hidaka T, Kambayashi Y, Furudate S, Kakizaki A, Tono H, Tsukada A, Haga T, Hashimoto A, Morimoto R, Yamaguchi T, Takano T, Aiba S.

Oncotarget. 2017 Apr 13;8(41):71181-71187. doi: 10.18632/oncotarget.17090. eCollection 2017 Sep 19.

50.

Diagnostic value of urinary CXCL10 as a biomarker for predicting Hunner type interstitial cystitis.

Niimi A, Igawa Y, Aizawa N, Honma T, Nomiya A, Akiyama Y, Kamei J, Fujimura T, Fukuhara H, Homma Y.

Neurourol Urodyn. 2018 Mar;37(3):1113-1119. doi: 10.1002/nau.23431. Epub 2017 Oct 19.

PMID:
29048741

Supplemental Content

Loading ...
Support Center